Keeson Technology Corporation announced that the closing price increase deviation of the company's stocks reached 20% over three consecutive trading days, on December 17, 18, and 19, which constitutes an abnormal fluctuation in stock trading. After self-examination by the company's Board of Directors and inquiries to the controlling shareholder and actual controller, there has been no significant information that should have been disclosed but was not disclosed as of the announcement date. The company's production and operation are currently normal, with no significant matters that should have been disclosed but were not disclosed, including but not limited to major asset restructuring, issuing shares, acquisitions of listed companies, debt restructuring, business restructuring, asset stripping, and asset injection. The company's directors, supervisors, senior management, and controlling shareholders did not buy or sell company stocks during the period of abnormal stock fluctuation. The company does not have other circumstances that violate fair information disclosure regulations.